| Dr Cristian R Del Carpio Tenorio, MD | |
|
1001 E Osceola Pkwy Ste 3200, Kissimmee, FL 34744-1616 | |
| (321) 841-6444 | |
| (407) 650-1307 |
| Full Name | Dr Cristian R Del Carpio Tenorio |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 20 Years |
| Location | 1001 E Osceola Pkwy Ste 3200, Kissimmee, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184887903 | NPI | - | NPPES |
| 7100296920 | Medicaid | KY | |
| 106093400 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | ME131679 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tallahassee Memorial Healthcare | Tallahassee, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tallahassee Memorial Healthcare Inc | 6103724778 | 322 |
| Orlando Health Medical Group Inc | 9537059084 | 1417 |
News Archive
Lower-income patients want to communicate electronically with their doctors, but the revolution in health care technology often is not accessible to them, due to inadequate health information services within the health care clinics they frequent, according to a survey by UC San Francisco researchers.
Arena Pharmaceuticals, Inc. reported that positive data from a clinical trial evaluating the abuse potential of lorcaserin were presented in a poster session at the 48th Annual Meeting of the American College of Neuropsychopharmacology. Data from the trial demonstrate that the risk for abuse associated with lorcaserin is very low.
Controlling depression in patients with heart failure can improve health status, social functioning and quality of life, according to a new study by psychiatrists and cardiologists at the UC Davis and Duke University schools of medicine.
A study by UCLA researchers shows that in people with mild cases of COVID-19, antibodies against SARS-CoV-2 - the virus that causes the disease - drop sharply over the first three months after infection, decreasing by roughly half every 73 days.
› Verified 7 days ago
| Entity Name | Tallahassee Memorial Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437177664 PECOS PAC ID: 6103724778 Enrollment ID: O20031222000279 |
News Archive
Lower-income patients want to communicate electronically with their doctors, but the revolution in health care technology often is not accessible to them, due to inadequate health information services within the health care clinics they frequent, according to a survey by UC San Francisco researchers.
Arena Pharmaceuticals, Inc. reported that positive data from a clinical trial evaluating the abuse potential of lorcaserin were presented in a poster session at the 48th Annual Meeting of the American College of Neuropsychopharmacology. Data from the trial demonstrate that the risk for abuse associated with lorcaserin is very low.
Controlling depression in patients with heart failure can improve health status, social functioning and quality of life, according to a new study by psychiatrists and cardiologists at the UC Davis and Duke University schools of medicine.
A study by UCLA researchers shows that in people with mild cases of COVID-19, antibodies against SARS-CoV-2 - the virus that causes the disease - drop sharply over the first three months after infection, decreasing by roughly half every 73 days.
› Verified 7 days ago
| Entity Name | Orlando Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669429577 PECOS PAC ID: 9537059084 Enrollment ID: O20040318000044 |
News Archive
Lower-income patients want to communicate electronically with their doctors, but the revolution in health care technology often is not accessible to them, due to inadequate health information services within the health care clinics they frequent, according to a survey by UC San Francisco researchers.
Arena Pharmaceuticals, Inc. reported that positive data from a clinical trial evaluating the abuse potential of lorcaserin were presented in a poster session at the 48th Annual Meeting of the American College of Neuropsychopharmacology. Data from the trial demonstrate that the risk for abuse associated with lorcaserin is very low.
Controlling depression in patients with heart failure can improve health status, social functioning and quality of life, according to a new study by psychiatrists and cardiologists at the UC Davis and Duke University schools of medicine.
A study by UCLA researchers shows that in people with mild cases of COVID-19, antibodies against SARS-CoV-2 - the virus that causes the disease - drop sharply over the first three months after infection, decreasing by roughly half every 73 days.
› Verified 7 days ago
| Entity Name | Tallahassee Memorial Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194774968 PECOS PAC ID: 6103724778 Enrollment ID: O20041029000600 |
News Archive
Lower-income patients want to communicate electronically with their doctors, but the revolution in health care technology often is not accessible to them, due to inadequate health information services within the health care clinics they frequent, according to a survey by UC San Francisco researchers.
Arena Pharmaceuticals, Inc. reported that positive data from a clinical trial evaluating the abuse potential of lorcaserin were presented in a poster session at the 48th Annual Meeting of the American College of Neuropsychopharmacology. Data from the trial demonstrate that the risk for abuse associated with lorcaserin is very low.
Controlling depression in patients with heart failure can improve health status, social functioning and quality of life, according to a new study by psychiatrists and cardiologists at the UC Davis and Duke University schools of medicine.
A study by UCLA researchers shows that in people with mild cases of COVID-19, antibodies against SARS-CoV-2 - the virus that causes the disease - drop sharply over the first three months after infection, decreasing by roughly half every 73 days.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cristian R Del Carpio Tenorio, MD 1001 E Osceola Pkwy Ste 3200, Kissimmee, FL 34744-1616 Ph: (321) 841-6444 | Dr Cristian R Del Carpio Tenorio, MD 1001 E Osceola Pkwy Ste 3200, Kissimmee, FL 34744-1616 Ph: (321) 841-6444 |
News Archive
Lower-income patients want to communicate electronically with their doctors, but the revolution in health care technology often is not accessible to them, due to inadequate health information services within the health care clinics they frequent, according to a survey by UC San Francisco researchers.
Arena Pharmaceuticals, Inc. reported that positive data from a clinical trial evaluating the abuse potential of lorcaserin were presented in a poster session at the 48th Annual Meeting of the American College of Neuropsychopharmacology. Data from the trial demonstrate that the risk for abuse associated with lorcaserin is very low.
Controlling depression in patients with heart failure can improve health status, social functioning and quality of life, according to a new study by psychiatrists and cardiologists at the UC Davis and Duke University schools of medicine.
A study by UCLA researchers shows that in people with mild cases of COVID-19, antibodies against SARS-CoV-2 - the virus that causes the disease - drop sharply over the first three months after infection, decreasing by roughly half every 73 days.
› Verified 7 days ago
Dr. Mohammad T Siddiqui, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1101 N Central Ave, Kissimmee, FL 34741 Phone: 407-851-5600 Fax: 407-438-0507 | |
Dr. Giovanni Hernandez, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1178 Cypress Glen Circle, Kissimmee, FL 34741 Phone: 407-943-8883 Fax: 407-943-8854 | |
Sidi A Elalaoui, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1952 N John Young Pkwy, Kissimmee, FL 34741 Phone: 407-343-1284 Fax: 407-343-1286 | |
Basher M Atiquzzaman, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2400 N Orange Blossom Trail, Suite 302, Kissimmee, FL 34744 Phone: 407-932-6193 Fax: 407-932-6194 | |
Dr. Mukesh Kumar, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 601 Oak Commons Blvd, Kissimmee, FL 34741 Phone: 407-846-0626 Fax: 407-846-2371 | |
Dr. Adam L Griggs, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1121 N Central Ave, Suite B, Kissimmee, FL 34741 Phone: 407-933-1221 Fax: 407-933-0747 | |
Sajid Chaudhary, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 102 Park Place Blvd., Bldg D, Suite 2 &3, Kissimmee, FL 34741 Phone: 407-279-5069 Fax: 407-378-3076 |